Related references
Note: Only part of the references are listed.Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop 2009
Cliodna A. M. McNulty et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
GAVI's Advance Market Commitment Response
Nina Schwalbe et al.
LANCET (2010)
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
Rebecca R. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Why did it take the infectious diseases society of America so long to address the problem of antibiotic resistance?
Calvin M. Kunin
CLINICAL INFECTIOUS DISEASES (2008)
Clinical implications of antimicrobial resistance for therapy
Alasdair P. MacGowan
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
The profit problem in antibiotic R&D
C Nathan et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Why is big Pharma getting out of antibacterial drug discovery?
SJ Projan
CURRENT OPINION IN MICROBIOLOGY (2003)
Share Paper
